Semi-Annual Statement Of Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7584308

Concept 2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
2021-04-01 to
2021-09-30
Semi-annual statement of income
Statement of income
Net sales
JPY
36,819,000,000 JPY
1,219,000,000 JPY
35,600,000,000 JPY
36,819,000,000 JPY
37,588,000,000 JPY
36,396,000,000 JPY
JPY
37,588,000,000 JPY
1,192,000,000 JPY
Cost of sales
16,432,000,000 JPY
16,588,000,000 JPY
Gross profit (loss)
20,387,000,000 JPY
20,999,000,000 JPY
Ordinary profit (loss)
8,555,000,000 JPY
9,290,000,000 JPY
Selling, general and administrative expenses
12,178,000,000 JPY
11,963,000,000 JPY
Extraordinary income
4,000,000 JPY
195,000,000 JPY
Extraordinary losses
330,000,000 JPY
49,000,000 JPY
Selling, general and administrative expenses
Salaries
2,815,000,000 JPY
2,877,000,000 JPY
Profit (loss) before income taxes
8,229,000,000 JPY
9,436,000,000 JPY
Operating profit (loss)
JPY
8,209,000,000 JPY
616,000,000 JPY
7,592,000,000 JPY
8,209,000,000 JPY
9,036,000,000 JPY
8,401,000,000 JPY
JPY
9,036,000,000 JPY
635,000,000 JPY
Non-operating income
358,000,000 JPY
278,000,000 JPY
Non-operating income
Interest income
3,000,000 JPY
3,000,000 JPY
Dividend income
233,000,000 JPY
214,000,000 JPY
Income taxes
2,265,000,000 JPY
2,714,000,000 JPY
Non-operating expenses
12,000,000 JPY
23,000,000 JPY
Profit (loss)
5,964,000,000 JPY
6,721,000,000 JPY
Non-operating expenses
Interest expenses
8,000,000 JPY
8,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
2,000,000 JPY
195,000,000 JPY
Extraordinary losses
Impairment losses
304,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.